Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-06
DOI
10.1038/srep45954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells
- (2016) Ulises Urzúa et al. BMC GENOMICS
- Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells
- (2016) R. Bhattacharya et al. CANCER RESEARCH
- Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients
- (2016) C. Marchetti et al. CANCER TREATMENT REVIEWS
- VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells
- (2016) Irina V. Tiper et al. CLINICAL CANCER RESEARCH
- Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials
- (2016) Taner Korkmaz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeted agents and combinations in ovarian cancer: where are we now?
- (2016) Jennifer McLachlan et al. Expert Review of Anticancer Therapy
- Abstract P4-01-16: Detection of EMT, anoikis and stem cell markers in metastatic breast cancer patients under different lines of treatment
- (2015) Elisabeth K Trapp et al. CANCER RESEARCH
- State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer
- (2015) Whitney Graybill et al. GYNECOLOGIC ONCOLOGY
- Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
- (2015) Majid Momeny et al. Oncotarget
- Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms
- (2014) Alessandra Decio et al. AMERICAN JOURNAL OF PATHOLOGY
- High Incidence of ErbB3, ErbB4, and MET Expression in Ovarian Cancer
- (2014) Suzy Davies et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Reliable in vitro studies require appropriate ovarian cancer cell lines
- (2014) Francis Jacob et al. Journal of Ovarian Research
- VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2
- (2014) Jaeyoung Lim et al. NEOPLASIA
- Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2
- (2013) Kuo-Tai Hua et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications
- (2013) Ramez N. Eskander et al. GYNECOLOGIC ONCOLOGY
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
- (2013) A. Vecchione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly
- (2012) Qinglian Hu et al. BIOMATERIALS
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
- (2012) Bradley J. Monk et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery
- (2012) J P H Chow et al. ONCOGENE
- Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
- (2011) Samar Masoumi Moghaddam et al. CANCER AND METASTASIS REVIEWS
- MMP-2 functions as an early response protein in ovarian cancer metastasis
- (2011) Hilary A. Kenny et al. CELL CYCLE
- Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors
- (2011) F. A. L. M. Eskens et al. CLINICAL CANCER RESEARCH
- The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer
- (2011) Ke-Jin Huang et al. MEDICAL ONCOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Peritoneal carcinosis of ovarian origin
- (2010) Anna Fagotti World Journal of Gastrointestinal Oncology
- The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
- (2009) X B Trinh et al. BRITISH JOURNAL OF CANCER
- Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis
- (2009) Jill K. Slack-Davis et al. CANCER RESEARCH
- First-line treatment of advanced ovarian cancer: current research and perspectives
- (2009) Claudia Marchetti et al. Expert Review of Anticancer Therapy
- VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion
- (2009) Feng-qiang Wang et al. GYNECOLOGIC ONCOLOGY
- In vivo properties of the proangiogenic peptide QK
- (2009) Gaetano Santulli et al. Journal of Translational Medicine
- Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
- (2009) L. Crombez et al. NUCLEIC ACIDS RESEARCH
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Involvement of Vascular Endothelial Growth Factor in the Survival of Hypoxic Colon Cancer Cells
- (2008) M. Calvani et al. CANCER RESEARCH
- New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents
- (2008) Phuong Dinh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis
- (2008) Ifat Sher et al. INTERNATIONAL JOURNAL OF CANCER
- Functional significance of VEGFR-2 on ovarian cancer cells
- (2008) Whitney A. Spannuth et al. INTERNATIONAL JOURNAL OF CANCER
- The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
- (2008) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Events in the Pathogenesis of Epithelial Ovarian Cancer
- (2008) Charles N. Landen et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiogenesis as a strategic target for ovarian cancer therapy
- (2008) Whitney A Spannuth et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search